Sorafenib FDA approval date

The FDA approved Sorafenib (Nexavar) on 1 Dec 2005.

FDA approval date
1 Dec 2005

Drug identity checked against registry records

Also recorded as Nexavar; Nexavar®

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2005-12-01DaySorafenibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA021923", "applicant_as_listed_by_fda": "BAYER HLTHCARE", "brand_names": ["NEXAVAR"], "active_ingredients": ["SORAFENIB TOSYLATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20051201", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026